HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Similar documents
Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction

Drug Use, Harm Reduction, and HIP

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Historical Perspectives

Training Objectives. By the end of this session you will be able to: 2. Recognize key principles of harm reduction.

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Harm Reduction 3/5/2019. Topics for Today. Working Definition of Harm Reduction. Scott Stokes Section Chief, Substance Abuse Services

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

The Principles of Harm Reduction

New London CARES Coordinated Access, Resources, Engagement and Support

Opiate Use Disorder and Opiate Overdose

HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Advocating for Syringe Exchange Programs

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Advancing Health Equity with Harm Reduction Strategies

Harm Reduction In our communities, in our hospitals. AARM Conference September 14, 2017 Angela Baird RN, BN

Incorporating Harm Reduction Strategies in Behavioral Health Grantmaking October 25, :00 p.m. Eastern

Protecting and Promoting Health and Equity

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

CitiWide Harm Reduction

State Opioid Response (SOR) Grant

As a result of this training, participants will be able to:

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Building Community Coalitions to Address the Opioid Crisis

Harm Reduction: Blending Principles and Practice

What is harm reduction?

Meeting People Where they Are: Hepatitis C, Wound care and Syringe Access. Heather Lusk, MSW

Opioid Overview Admiral Brett P. Giroir, M.D.

Building capacity for a CHC response to Ontario's Opioid Crisis

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

National Academy of Medicine Action Collaborative: Countering the US Opioid Epidemic

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

Part 1: Introduction & Overview

Medication Assisted Treatment

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Changing Course: statewide efforts to combat the opioid epidemic in California

The Opioid-Exposed Woman

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Community Response Addressing The Opioid Crisis. Leon, Wakulla, Gadsden, Franklin, Liberty, Jefferson, Madison and Taylor Counties

Combating Opiate Addiction

Questions & Answers. What are the risks associated with consumption drug use?

As a result of this training, participants will be able to:

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Prevention Point Philadelphia

Understanding the Opiate Epidemic

REPORT ON EXPLORATORY SITE VISITS FOR COMPREHENSIVE USER ENGAGEMENT SITE (CUES)

Opioid Overdose in Oregon Report to the Legislature

CFHA 18 th Annual Conference October 13-15, 2016 Charlotte, NC U.S.A. Session # A1

The Principles of Harm Reduction

Public Health Association of British Columbia

Methadone Maintenance 101

Brief History of Methadone Maintenance Treatment

7/31/18. Justin McClenny, LCDC

Successful Prevention Strategies to Address the Opioid Crises

CPAA Opioid Response Workgroup Meeting

AIDS Foundation of Chicago Strategic Vision

Albuquerque Health Care for the Homeless (AHCH)

Syringe Exchange Programs December 2005

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Open Recovery Ending the Stigma Fueling Addiction

Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better.

Family Health Centers of San Diego Alcohol and Other Drug Services

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

The science of the mind: investigating mental health Treating addiction

High Impact Prevention for People Who Inject Drugs. June 30, 2015

Models of good practice in drug treatment in Europe. Project group

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0

The impact of economic recession on drug users and drug treatment

Drug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations

Jefferson County Syringe Exchange Program (SEP) Annual Report 2017

Patient and Family Agreement on Opioids

Opioid Addiction Statistics

CDC s Efforts to End the Opioid Epidemic

Take Home Naloxone Report on supply and use to reverse an overdose

OPIOID WORKGROUP LEADERSHIP TEAM

Improving Clinical Responses to Drug-Related Deaths. Presented by: Dr Prun Bijral Medical Director Date: 15 th November 2017

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach

OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

ESTABLISHMENT OF SUPERVISED INJECTING FACILITY IN VICTORIA SUBMITTED BY THE SALVATION ARMY

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

Project Connections Buprenorphine Program

Overdose Fatality Review Presentation of Annual Reports. Erin Haas and Laura Bartolomei-Hill Maryland Department of Health

What s The Harm? Conference 2015: Where are we now.what s Next? Beth Whalen

Transcription:

HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe access Advocacy and policy

THE CURRENT STATE OF THE OPIOID EPIDEMIC

OVERDOSE DEATH TRENDS: THE CURRENT U.S. EPIDEMIC Overdose is the leading cause of accidental death in the U.S. 5x higher in 2016 than in 1999 2016: The number of overdose deaths surpassed the death toll from HIV at the peak of the HIV epidemic in 1995 >42,000 of the 53,000 OD deaths in 2016 involved

OVERDOSE DEATH TRENDS: THE CURRENT U.S. EPIDEMIC 2014-2015: Death rate from synthetic opioids (other than methadone) increased by 72.2% Increased presence of fentanyl in street drugs Heroin death rates also increased by 20.6%

FENTANYL Synthetic opioid that is 50x more potent than heroin and 100x more potent than morphine Illicitly manufactured fentanyl cut and mixed with other opioids has led to a dramatic increase in overdose deaths

OBSTACLES FACED BY DRUG USERS DRUG-RELATED STIGMA Risk of incarceration Barriers to employment, health care, housing, education and assistance Drug treatment: one-size-fits-all approach, moral over evidence-based

FEAR OF ARREST Only in about half of personal or witnessed overdose experiences did someone call 911 or seek medical assistance Fear of arrest cited as primary reason

WHAT IS HARM REDUCTION?

HARM REDUCTION = COMMON SENSE Pragmatic, evidence-based approach to dealing with substance use Aims to mitigate harmful consequences of drug use Respect and affirm dignity of people who use drugs Meet people where they re at

HARM REDUCTION INTERVENTIONS Overdose prevention/naloxone distribution programs Syringe exchange programs Safe injection facilities Opioid replacement therapy Housing first

A BRIEF HISTORY OF HARM REDUCTION 1970s-1980s: Community responses to reducing transmission of HIV and Hepatitis 1980s: First syringe access programs 2000s: Buprenorphine and naltrexone prescribed for opioid dependence

HISTORICAL CHALLENGES Opposition from federal government Many people condemned the use of certain drugs associated with stigmatized minority groups Policy and science favored abstinence as the only effective solution Researchers viewed as a disease; general public viewed as a moral failing

HARM REDUCTION TODAY Over 300 syringe service programs in 39 states in the U.S., Washington D.C. and Puerto Rico Many offer services including condom distribution, treatment referrals, counseling and testing for HIV and Hepatitis, overdose education and naloxone distribution HR strategies now expanding to other healthcare settings

HARM REDUCTION CHALLENGES TODAY Many people in rural and suburban areas lack access to harm reduction programs Can collect data on distribution of supplies but documenting overdose reversals is difficult Government grants fund naloxone distribution for emergency responders but not laypeople

KEY CONCEPTS OF HARM REDUCTION

RESPECT & DIGNITY Drug use is not wrong or immoral People who use drugs are more than their drug use Listen to and affirm the person s feelings and experiences Build relationships and trust

PRAGMATISM Drug use results from individual and environmental circumstances Drug use can meet important needs Strive to understand why this person uses and what they get out of using Avoid unrealistic expectations no one has perfect health behaviors

DRUG USE HARM Harm is relative, and not all use is chaotic Drug user has an intimate, complex relationship with drug(s), may involve both benefits and risks Focus on negative consequences of use rather than assuming that all use is harmful Deconstruct the person s drug use determine what they find problematic

AUTONOMY Listen to the person s needs Value the person s expertise and life experience Involve the person in decision-making, goal-setting and treatment plan Self-efficacy inspires motivation, leading to growth and change

INDIVIDUALIZED TREATMENT PLANS Offer a range of options to ensure best outcomes Abstinence is one of many possible goals Work together to come up with a tailored plan based on their strengths and abilities Help motivate the person to make progress toward the goals you set together

ANY POSITIVE CHANGE Prioritize improvement of quality of life rather than cessation of all drug use Incremental change is better than no change at all Measure progress in health, social and economic outcomes rather than changes in use

ACCEPTANCE Backtracking is part of the process Do not punish or reject for not achieving goals Use positive reinforcement, focus on what the person is doing well Avoid judgment or condemnation There should be no requirements for treatment

SUMMARY OF PRINCIPLES Drug abuse is a health concern, not a legal or moral issue Not all drug use is abuse People use drugs for specific reasons Drug use occurs on a continuum from mild to severe harm is relative Incremental change is normal and motivation is fluid

HARM REDUCTION PRACTICES

KEY SYSTEMATIC DIFFERENCES STRUCTURAL PHILOSOPHY SYSTEM DESIGN PROVIDER PERSPECTIVE ON APPROACH TO CARE PROVIDER ROLE USER ROLE TRADITIONAL MEDICAL MODEL Hierarchical chain of command with provider as expert Provider designates procedures for care Expert knowledge Prescribe treatment; seek compliance and adherence Accept and comply with treatment recommendations LOCUS OF CONTROL Physician-centered User-centered HARM REDUCTION MODEL Inclusion; community decision-making; process Low threshold for care access; focus on reciprocal learning; patient-driven care Continuously question assumptions; avoid judgment; be attentive to patient needs Collaborative decision-making; patient education Understand options, active involvement in care choices, strive for incremental changes to reduce harms

HOW MEDICAL PROFESSIONALS CAN PRACTICE HARM REDUCTION Encourage people to take small steps forward to reduce the harmful effects of drug use, particularly overdose, HIV, hepatitis C and other blood-borne infections Make support and compassionate care accessible Listen in order to build trust and look for teachable moments Share medical knowledge, skills, and items people can use

HOW MEDICAL PROFESSIONALS CAN PRACTICE HARM REDUCTION Help people make small changes that have tangible results Learn as much as possible about people s decision-making and life circumstances and support the whole person Consider the root causes of people s health issues Focus on the person instead of the behavior and point out what they are doing well Refer people to community resources

OTHER RECOMMENDATIONS Provide staff with educational sessions and training workshops in harm reduction and overdose prevention Use motivational interviewing techniques with clients Ensure agency is equipped to provide trauma-informed care

QUESTIONS? CONTACT INFO: Chelsea Rainwater chelrainwater@gmail.com 225-907-5699 No Overdose Baton Rouge: noodbr@gmail.com